Thrombotic microangiopathy: A new dose-limiting toxicity of high-dose sequential chemotherapy

Bone Marrow Transplantation

Volumn 27, Issue 5, 2001, Pages 531-536

  Vantelon, J M ^a   Munck, J N ^a   Bourhis, J H ^a   Pico, J L ^a   Fadel, C ^a   Ulusakarya, A ^a   Carde, P ^a   Fenaux, P ^a   Ribrag, V ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Chemotherapy; Lymphoma; Thrombotic microangiopathy

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; METHOTREXATE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TENIPOSIDE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COOMBS TEST; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; HEART FAILURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC ANEMIA; HEMORRHAGIC CYSTITIS; HUMAN; KIDNEY DISEASE; LEUKAPHERESIS; MALE; MUCOSA INFLAMMATION; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PILOT STUDY; PNEUMONIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANEMIA, HEMOLYTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIUM, VASCULAR; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; PILOT PROJECTS; THROMBOSIS; TREATMENT OUTCOME;

EID: 0035071716     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702812     Document Type: Article

References (28)

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
2. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte
3. Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial
4. Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: A novel and delivering multiple courses of dose-intensive therapy
5. Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma
6. Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumors
7. Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients
8. Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: A phase I/II study in advanced ovarian cancer
9. Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cells
10. Thrombotic thrombocytopenic purpura: Diagnosis, pathogenesis and modern therapy
11. Von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura
12. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
13. Report of an international Workshop to standardize response criteria for non-Hodgkin's lymphomas
14. Principles of the clinical evaluation of biologic agents
15. Bone marrow transplant-associated thrombotic microangiopathy: A case series
16. Thrombotic microangiopathy following bone marrow transplantation
17. Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer
18. Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation
19. The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients
20. Massive myocardial necrosis in thrombotic thrombocytopenic purpura: A case report and review of the literature
21. Sudden cardiac death from thrombotic thrombocytopenic purpura
22. Respiratory dysfunction in thrombotic thrombocytopenic purpura
23. Cardiac manifestations of thrombotic thrombocytopenic purpura
24. Thrombotic thrombocytopenic purpura in pulmonary-renal syndromes
25. Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer
26. Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: A feasibility study
27. Non-haematological toxicity limiting the application of sequential high dose chemotherapy in patients with advanced breast cancer
28. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: Is there a chance for cure?